To study the mechanism of vasodilation induced by 6-(3-dimethylaminopropionyl) forskolin (NKH477), a water-soluble forskolin derivative, its effects on the acetylcholine (ACh)-induced contraction of muscle strips of porcine coronary artery were examined. [Ca2"]1, isometric force, and cellular concentrations of cAMP and inositol 1,4,5-trisphosphate were measured. NKH477 (0.1-1.0 ,uM), isoproterenol (0.01-0.1 uM), or forskolin (0.1-1.0 ,uM) increased cAMP and attenuated the contraction induced by 128 mM K' or 10 ,M ACh in a concentration-dependent manner. These agents, at concentrations up to 0.3 LM, did not change the amount of cGMP. NKH477 (0.1 gM) attenuated the contraction induced by 128 mM K' without corresponding changes in the evoked [Ca2+11 responses. ACh (10 ,uM) produced a large phasic increase followed by a small tonic increase in [Ca2+1i and produced a sustained contraction. The ACh-induced phasic increase in [Ca2+1], but not the tonic increase, disappeared after application of 0.1 ,M ionomycin. NKH477 (0.1 ,uM) attenuated both the increase in [Ca2+]i and the force induced by 10 ,uM ACh in muscle strips that were not treated with ionomycin and inhibited the ACh-induced contraction without corresponding changes in [Ca2+]i in ionomycin-treated muscle strips. These results suggest that NKH477 inhibits ACh-induced Ca2+ mobilization through its action on ionomycin-sensitive storage sites. In ionomycin-treated and 128 mM K'-treated muscle strips, 0.1 ,uM NKH477 shifted the [Ca2+1f-force relation to the right in the presence or absence of 10 piM ACh. In 3-escin-skinned smooth muscle strips, 0.1 ,uM NKH477 shifted the pCa-force relation to the right but had no effects on Ca2+-independent contraction. We conclude that in smooth muscle of porcine coronary artery, NKH477 inhibits ACh-induced contraction by both attenuating ACh-induced Ca2+ mobilization and reducing the sensitivity of the contractile machinery to Ca2 , possibly by activating cAMP-dependent mechanisms. (Circulation Research 1992;71:70-81) KEY WORDS * cAMP * forskolin derivative concentration * contractile proteins soproterenol inhibits agonist-stimulated smooth muscle contraction by increasing the intracellular concentration of cAMP through its action on /3-adrenoceptors.' Although forskolin directly activates adenylate cyclase and has been used to study the roles of cAMP in cellular functions in various cell types,2 another direct activator of adenylate cyclase, N,N-dimethyl-,8-alanine [3R-(3a,4a/3,5f3,6,8,6aa,10a,10a,8, 10ba )]-5(acetyloxy)-3 -ethenyldodecahydro-10, 10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-1H-naphtho[2,1-b]pyran-6-yl ester hydrochloride (NKH477), has been recently introduced.3 Unlike forskolin, this agent is relatively soluble in water and is potentially useful for long-term intravenous infusion in patients with congestive heart * vascular smooth muscle * cellular Ca2f ailure, especially when these patients are relatively insensitive to ,B-adrenoceptor stimulants or to inhibitors of phosphodiesterase.
Mechanisms of Vasodilation
To study the mechanism of vasodilation induced by 6-(3-dimethylaminopropionyl) forskolin (NKH477), a water-soluble forskolin derivative, its effects on the acetylcholine (ACh)-induced contraction of muscle strips of porcine coronary artery were examined. [Ca2"]1, isometric force, and cellular concentrations of cAMP and inositol 1,4,5-trisphosphate were measured. NKH477 (0.1-1.0 ,uM), isoproterenol (0.01-0.1 uM), or forskolin (0.1-1.0 ,uM) increased cAMP and attenuated the contraction induced by 128 mM K' or 10 ,M ACh in a concentration-dependent manner. These agents, at concentrations up to 0.3 LM, did not change the amount of cGMP. NKH477 (0.1 gM) attenuated the contraction induced by 128 mM K' without corresponding changes in the evoked [Ca2+11 responses. ACh (10 ,uM) produced a large phasic increase followed by a small tonic increase in [Ca2+1i and produced a sustained contraction. The ACh-induced phasic increase in [Ca2+1], but not the tonic increase, disappeared after application of 0.1 ,M ionomycin. NKH477 (0.1 ,uM) attenuated both the increase in [Ca2+]i and the force induced by 10 ,uM ACh in muscle strips that were not treated with ionomycin and inhibited the ACh-induced contraction without corresponding changes in [Ca2+]i in ionomycin-treated muscle strips. These results suggest that NKH477 inhibits ACh-induced Ca2+ mobilization through its action on ionomycin-sensitive storage sites. In ionomycin-treated and 128 mM K'-treated muscle strips, 0.1 ,uM NKH477 shifted the [Ca2+1f-force relation to the right in the presence or absence of 10 piM ACh. In 3-escin-skinned smooth muscle strips, 0.1 ,uM NKH477 shifted the pCa-force relation to the right but had no effects on Ca2+-independent contraction. We conclude that in smooth muscle of porcine coronary artery, NKH477 inhibits ACh-induced contraction by both attenuating ACh-induced Ca2+ mobilization and reducing the sensitivity of the contractile machinery to Ca2 , possibly by activating cAMP-dependent mechanisms. (Circulation Research 1992;71:70-81) KEY WORDS * cAMP * forskolin derivative concentration * contractile proteins soproterenol inhibits agonist-stimulated smooth muscle contraction by increasing the intracellular concentration of cAMP through its action on /3-adrenoceptors.' Although forskolin directly activates adenylate cyclase and has been used to study the roles of cAMP in cellular functions in various cell types,2 another direct activator of adenylate cyclase, N,N-dimethyl-,8-alanine[3R-(3a,4a/3,5f3,6,8,6aa,10a,10a,8, 10ba)]-5(acetyloxy)-3 -ethenyldodecahydro-10, 10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-1H-naphtho[2,1-b]pyran-6-yl ester hydrochloride (NKH477), has been recently introduced.3 Unlike forskolin, this agent is relatively soluble in water and is potentially useful for long-term intravenous infusion in patients with congestive heart * vascular smooth muscle * cellular Ca2f ailure, especially when these patients are relatively insensitive to ,B-adrenoceptor stimulants or to inhibitors of phosphodiesterase.
Two hypotheses have been proposed to explain the mechanisms of vasodilation induced by agents that increase cAMP. One is that cAMP decreases [Ca2"Ji and then produces vasodilation. This action is caused by the inhibition of Ca`+ influx,4-6 by the activation of Ca`+ sequestration,7-10 or by the activation of Ca`+ extrusion to the extracellular space."1 cAMP also inhibits agonistinduced increases in [Ca'+]i by inhibiting the synthesis of inositol 1,4,5-trisphosphate (IP3)12-14 or by the phosphorylation of the IP3 receptor.1516 The second hypothesis is that cAMP decreases the affinity of myosin light chain kinase for the Ca2-calmodulin complex through the phosphorylation of myosin light chain kinase and thus inhibits phosphorylation of myosin light chains, causing inhibition of agonist-induced contraction.17 '18 It was reported that in ferret aorta, [Ca2] ,-force and [Ca2]i-myosin phosphorylation curves (but not the phosphorylation-force curve) were shifted to the right by forskolin in the presence of high K .'9 This may support the above-mentioned hypothesis. However, it was recently found that stimulation of cAMP formation results in relaxation, with different effects obtained with agonist-induced contractions versus high K'-induced contractions. 20 Kamm and Stul12' also suggested that the phosphorylation of myosin light chain kinase by cAMPdependent protein kinase would play only a minor role in the vasodilation induced by agents that increase cAMP under physiological conditions. Thus, the mechanisms of vasodilation induced by agents that increase cAMP have not yet been determined.
To explore these possibilities, we investigated the effects of NKH477 on the relation between [Ca21]i and force and during agonist-induced stimulation of endothelium-denuded strips of porcine coronary artery smooth muscle. The relation between [Ca21]i and force was also studied in depolarized smooth muscle strips in which Ca21 storage sites were functionally removed with ionomycin. The effects of NKH477 on contractile proteins were studied by examining the Ca2+-induced contraction of f,-escin-skinned smooth muscle of the porcine coronary artery.
Materials and Methods Drugs
Drugs used were fura-2, fura-2 AM, EGTA, PIPES, HEPES, and MOPS (Dojin, Japan); GTP, calmodulin, and 1-escin (Sigma Chemical Co., St. Louis, Mo.); isoproterenol (Nacalai, Japan); ATP (sodium salt, Kojin, Japan); ionomycin (Calbiochem Corp., La Jolla, Calif.); adenosine 5'-0-(3-thiotriphosphate) (ATPyS, Boehringer Mannheim-Yamanouchi, Japan); acetylcholine HCI (Daiichi, Japan); and NKH477 (Nippon Kayaku Ltd., Japan). Forskolin was kindly provided by Nippon Kayaku.
Materials
The left anterior descending branch of the coronary artery was excised at room temperature from fresh porcine hearts. Arteries in Krebs' solution were rinsed free of blood, and connective tissue was removed under a binocular microscope.
Recording of Mechanical Activity
Circularly cut strips (length, 0.3-0.5 mm; width, 0.07 mm; thickness, 0.03-0.05 mm) of the porcine coronary artery were prepared, and endothelial cells were removed by gentle rubbing of the intimal surface with a small razor blade, as reported previously.22 Strips were then transferred to a small 0.5-ml chamber through which test solutions could be changed rapidly by injecting fresh solution at one end and simultaneously draining the other end with a water pump. Both ends of the preparation were fixed between pieces of Scotch double-sided tape with thin silk threads, and isometric force was recorded using a strain gauge transducer (U-gauge, Shinko Co., Tokyo). Resting force was adjusted to obtain a maximal contraction in 128 mM K'. In the present experiments, removal of endothelium was not confirmed histologically; instead, functional removal of the endothelium in the strips was shown by the effect of 0.1 ,uM calcium ionophore A23187 on the tonic contraction induced by 0.3 ,uM acetylcholine (ACh), as described previously.23 All experiments were performed at room temperature (23-25°C).
Simultaneous Recording of Ca2' and Force
To permit the simultaneous recording of [Ca2"Ii and isometric force, fine circularly cut strips (length, 0.3-0.5 mm; width, 0.04-0.05 mm; thickness, 0.02-0.03 mm) were prepared. Endothelial cells were removed, as described above. The strips were transferred to a chamber of 0.3-ml volume and mounted horizontally on an inverted microscope (Diaphot TMD with special optics for epifluorescence, Nikon, Tokyo). Resting force was adjusted to obtain a maximal contraction in 128 mM K'.
To load fura-2 into smooth muscle cells of the strip, 1 gM acetoxymethyl ester of fura-2 (fura-2 AM) dissolved in dry dimethyl sulfoxide (1 mM stock solution) was applied for 1 hour in Krebs' solution at room temperature (23-25°C). The strip was moved to the center of the field, and a mask (0.04-mm square) was placed in an intermediate image plane of the microscope to reduce background fluorescence. The fura-2 fluorescence emission at 510 nm (passed through an interference filter centered at 510 nm with a full width at half transmission of 20 nm) was passed through the objective lens (x20 Fluor, Nikon) and collected with a photomultiplier tube (side-on type, model R928, Hamamatsu Photonics, Japan) via a dichroic mirror (model DM-400, Nikon), which was substituted for the photochanger in a Nikon Diaphot TMD microscope. Two alternative excitation wavelengths, 340 and 380 nm (each slit, 5 nm), were applied by a spectrofluorimeter (SPEX Industries, Inc., Edison, N.J.), and the data were analyzed using customized software (DM-3000cM, SPEX). The ratio of the fura-2 fluorescence intensities excited at 340 and 380 nm was calculated after subtraction of the background fluorescence. Background fluorescence (including the autofluorescence of the strip) excited at 340 and 380 nm UV light was measured after application of a solution containing 50 ,uM ionomycin, 20 mM MnCl2, 110 mM KCI, and 10 mM MOPS (pH 4.8) after the experiment. Mn2' quenches the fura-2 fluorescence but does not affect the autofluorescence of the cells, the fluorescence of the acetoxymethyl ester,24 or the partial hydrolyzed products of fura-2 AM.25 Under these conditions, the background fluorescence intensity was 10-15% of the fura-2 signals in smooth muscle strips at either excitation wavelength. Cytosolic Ca21 concentrations were calculated using the formula described by Grynkiewicz et a126 and in vitro calibration.2728 The ratio of maximum fluorescence (Fm,) to minimum fluorescence (Fmin) was determined in the calibration solution after subtraction of background excited at either 340 or 380 nm, and the 380-nm signals of fura-2 were assumed to decrease by 15% in the cell because of the possible intracellular viscosity effects of the dye.27 '28 The Kd value for fura-2 was estimated to be 200 nM. 28 To compare the effects of drugs in intact and skinned smooth muscle strips and to prevent the extrusion of fura-2,29 the present experiments were done at room temperature.
We also tried, unsuccessfully, to estimate [Ca21]i using an internal calibration method in some strips.30 Briefly, the minimum fluorescence ratio (340/380) of the strip was obtained by application of Ca2+-free solution containing 10 mM EGTA with 100 mM K' and 10 mM MOPS at pH 8.5 followed by application of 50 ,uM ionomycin. Then, the solution containing 10 mM Ca2' with 100 mM K' and 10 mM MOPS (pH 8.5) was applied to get the maximum fluorescence ratio of the strip. Fma. and Fmjn were calculated after the subtraction of background fluorescence of the strip excited at either 340 or 380 nm. However, since the ratio of the Fmax was not constantly bigger than that of 128 mM K' in the Krebs' solution even in very thin strips, we could not use this method in the present experiment.
It has been suggested that, when fura-2 AM is used for loading fura-2 into the cells, problems in [Ca 2]i measurement may arise because of a possible amount of fura-2 AM remaining in the cells, partially hydrolyzed fluorescent intermediates of fura-2 AM, a formation of bleach intermediates of fura-2, and the possible loading of fura-2 into the cellular organella.29 More problems may arise in the tissue experiments than in the singlecell experiments. To avoid these possibilities as much as we can, we used a low concentration of fura-2 AM (1 MM), and the loading was done within 1 hour at room temperature using very small muscle strips, since a high concentration of fura-2 AM at a high temperature (32-37°C) would cause the heterogenous distribution of fura-2 in some cell types. 29 The time for application of the ultraviolet light was minimized (normally within 20-30 minutes for the total exposed time) since this may cause photobleached fluorescent derivatives of fura-2, as suggested previously.31 In the preliminary experiments we found that, before and after application of 1 ,M fura-2 AM for 1 hour, 10 ,M ACh could produce almost the same extent of contraction in the presence or absence of Ca'+, suggesting that fura-2 in the cells may not greatly influence this agonist-induced Ca 2 mobilization under the present conditions. Further, to get enough deesterification of fura-2 AM, we did some experiments using the muscle strips that were kept over 2 hours in the dark after removal of fura-2 AM. The effects of drugs used in the present experiments on
[Ca21]1 and force were identical compared with those observed in the strips kept for 1 hour after removal of fura-2 AM. However, we cannot deny the possibility that the calculated Ca 2 may not be accurate by the reasons described above.
Experiment on Chemically Skinned Smooth
Muscle Strips Chemically skinned smooth muscle strips were made using f3-escin. 32 The methods used to skin the muscle strips and the compositions of the solutions used have been described elsewhere.3233 lonomycin (1 ttM) was present throughout the experiment to deplete intracellular Ca21 stores. Assays for cAMP and cGMP Muscle strips of the porcine coronary artery were prepared as described above. NKH477, forskolin, or isoproterenol was applied for 3 minutes after the strips were equilibrated for 2 hours, and the reaction was halted by soaking the strips in ice-cold 8% trichloroacetic acid. The strips were then homogenized in the solution containing 8% trichloroacetic acid using a glass homogenizer. The homogenate was centrifuged, and the pellet was used for protein assay.34 The supernatant fraction was treated with water-saturated ether three times and assayed for cAMP and cGMP using radioim-
Measurement of IP3
Endothelium-denuded strips of the porcine coronary artery were equilibrated for over 2 hours at 32°C in Krebs' solution. After this, the strips were transferred to Ca2+-free Krebs' solution containing 2 mM EGTA for 2 minutes, and then 10 ,uM ACh was applied for 10 seconds. NKH477, isoproterenol, or forskolin was given during a 3-minute pretreatment in Krebs' solution, during a 2-minute pretreatment in Ca`4-free solution, and during the application of ACh. The reaction was stopped by the addition of a large amount of ice-cold 8% trichloroacetic acid, and the strips were homogenized. The homogenate was centrifuged, and the supernatant fraction was treated with water-saturated ether three times and assayed for 1P3 using a radioimmunoassay kit from Amersham International. Care was taken to maintain the pH of the homogenate at 9.0-9.5 to optimize the binding of the binding protein to 1P3. To minimize the loss of 1P3, Teflon tubes were used instead of glassware after homogenization. The pellet was used for protein assay.34
Solutions
The ionic composition of the Krebs' solution was as follows (mM): Na' 137.4, K' 5.9, Mg2+ 1.32, Ca2+ 2.6, HCO3-15.5, H2P04-1.2, Cl-134, and glucose 11.5. The concentration of K+ was modified by isosmotically replacing NaCl with KCl. Ca2+-free solution was made by substituting an equimolar concentration of MgCl2 for CaCl2 and adding 2 mM EGTA. The solutions were bubbled with 95% 02-5% C02, and their pH was maintained at 7.3-7.4.
The calibration solution for the Ca'+ measurements in intact strips contained 11 mM EGTA, 110 mM KCl, 1 mM MgCl2, 2 ,M fura-2, and 20 mM HEPES (pH 7.1) with or without 11 mM CaCl2. For experiments on skinned muscle, the composition of the relaxing solution was 87 mM potassium methanesulfonate (KMs), 20 mM PIPES, 5.1 mM Mg(Ms)2, 5.2 mM ATP, 10 mM phosphocreatine, 4 mM EGTA, and 1 ,M ionomycin. Various Ca2+ concentrations were obtained by adding appropriate amounts of Ca(Ms)2 to 4 mM EGTA, based on the calculation reported previously.33 The pH of the solution was adjusted to 7.1 at 25°C with KOH, and the ionic strength was standardized at 0.2 M by changing the amount of KMs added.
To get a Ca2+-independent contraction in the skinned strips, a solution containing ATP-yS and 0.3 ,uM Ca2+ or a rigor-producing solution was used. The ATPyS solution was composed of (mM) HEPES 20, Mg(Ms)2 2.6, 
Statistics
The values measured were expressed as mean±+SD.
Differences between means within each experiment were evaluated by analysis of variance. If significant differences were demonstrated, Student's paired or unpaired t test was used to determine which pairs of munoassay kits from Amersham International. means were significantly different. Values of p<0.05 were considered significant. Figure 1 shows the effects of isoproterenol, forskolin, and NKH477 on the amount of cAMP in smooth muscle strips of the porcine coronary artery. The amount of cAMP observed in the resting condition was 9.1±5.0 pmol/mg protein (n = 10). Isoproterenol (0.01-1 ,uM), NKH477 (0.1-1 ,uM), and forskolin (0.1-1 gM) increased the amount of cAMP in a concentration-dependent manner (Figure 1 ). The maximum effect obtained by 1 gM NKH477 or 1 gM forskolin was significantly larger than that induced by 0.1 gM isoproterenol (p<O.OS, n=8). The effect of 0.3 ,uM NKH477 was larger than that of 0. Effects of Isoproterenol, Forskolin, and NKH477 on the Contraction Induced by 128 mM K' or 10 uiMACh Figure 2 shows the effects of isoproterenol, forskolin, and NKH477 on the contraction induced by 128 mM K' (panel A) or 10 ,uM ACh (panel B) in smooth muscle strips of the porcine coronary artery. High K' (128 mM) produced a phasic and a subsequent tonic contraction in the muscle strips, and the latter response was maintained over 1 hour. ACh (10 gM) produced a monotonic contraction that was maintained over 30 minutes. The maximum amplitude of contraction induced by 10 gM ACh was 1.8±0.3 times that induced by 128 mM K' (n = 8). Isoproterenol, forskolin, or NKH477 was used to pretreat the strips for 5 minutes and was present throughout the application of 128 mM K' or 10 ,uM ACh. In the presence of 128 mM K', all drugs inhibited both the phasic and subsequent tonic contractions, but the phasic contractions were less sensitive than the tonic contractions (see Figure 3 for NKH477). Since 10 ,uM ACh slowly developed the force (=2 minutes to reach steady-state force), the effects of isoproterenol, forskolin, and NKH477 were observed at 2 minutes after the application of 128 mM K' or 10 ,uM ACh. Isoproterenol (0.01-0.1 gM), forskolin (0.01-1 ,uM), and NKH477 (0.01-1 ,uM) inhibited the contraction induced by 128 mM K' or 10 juM ACh in a concentration-dependent manner. The concentrations that produced half relaxation (IC50) of the high K'-induced contraction were 0.05±+0.02 ,uM for isoproterenol, 0.15+0.10 ,uM for forskolin, and 0.08±0.03 ,uM for NKH477 (n=4). IC50 values for the ACh-induced contraction were 0.05 + 0.02
Results

Effects of Isoproterenol, Forskolin, and NKH477 on Cellular Concentration of cAMP
,uM for isoproterenol, 0.17±0.07 ,uM for forskolin, and 0.07±0.03 ,uM for NKH477 (n=4-7).
The concentrations of isoproterenol, forskolin, and NKH477 necessary to inhibit the contraction induced by 128 mM K' or 10 ,uM ACh seemed to be well correlated with their effects on cAMP production. The order of potency of the above three cAMP-increasing agents for inhibition of the contraction induced by high K' or ACh was isoproterenol>NKH477>forskolin.
These results suggest that NKH477, a forskolin derivative, is a more potent cAMP-increasing vasodilator than forskolin in smooth muscle strips of the porcine coronary artery. ACh (10 jM) produced a large phasic increase followed by a small tonic increase in [Ca2"]i and a sustained contraction. The ACh-induced phasic and the subsequently generated tonic (measured at 2 minutes after the application) increases in [Ca2+]i were 600.8± 71.2 and 143.0±13.8 nM, respectively (n=4). The maximum force induced by 10 ,uM ACh was larger than that induced by 128 mM K', although the ACh-induced tonic increase in [Ca2+]i was much smaller than that induced by high K+.
When 0.1 ,M NKH477 was applied for 5 minutes before and during the application of 128 mM K' or 10 gM ACh, the resting [Ca2+Ii and force were slightly reduced. NKH477 (0.1 ,M) inhibited the amplitude of contraction induced by 10 ,tM ACh and decreased both the phasic and the tonic increases in [Ca2+]j. By contrast, 0.1 ,.M NKH477 inhibited both the phasic and the subsequently generated tonic contractions induced by 128 mM K', with a slight increase in [Ca21]i ( Figure 3 and Table 1 ).
Effects of NKH477 on Changes in [Ca2+], and Force
Induced by 128 mM K' or 10 ,uMACh in Ionomycin-Treated Muscle Strips cAMP increases Ca21 uptake into intracellular storage sites in smooth muscle of guinea pig and rabbit mesenteric arteries.7,8 To eliminate the effects of NKH477 on intracellular Ca21 storage sites, 0.1 paM ionomycin was applied 60 minutes before and during the application of 128 mM K' or Table 2 ).
Effects of NKH477 on [Ca2+]i -Force Relations in
Ionomycin-Treated Smooth Muscle Strips During Membrane Depolarization by 128 mM K'
To investigate the effects of NKH477 on [Ca2+]force relations, Ca2+-free solution containing 5.9 mM K' and 2 mM EGTA was first applied for 1 minute to ionomycin-treated smooth muscle strips, and then Ca2'free solution containing 128 mM K' and 2 mM EGTA was applied. At this point, various concentrations of Ca2' (0.16-2.6 mM) were cumulatively applied from low to high in the presence of 128 mM K'. After application of Ca2`-free solution with 5.9 mM K' for 1 minute, the resting [Ca21]i and force slightly decreased to 97.6+±33.2 nM and to 1.0±1.2 mg, respectively. Subsequently applied Ca2+-free solution with 128 mM K' did not increase [Ca21]i and force. Figure 
Effects of NKH477 on Ca2 --Force Relations in /3-Escin-Treated Skinned Smooth Muscle Strips
To investigate the action of 0.1 ,tM NKH477 on the contractile proteins more directly, the effects on Ca?+induced contraction were observed in the presence of 1 ,M ionomycin in f,-escin-treated skinned smooth muscle strips. In the skinned strips, the minimum concentration of Ca21 that produced the contraction was 0.3 ,uM, and the maximum contraction was obtained at 10 Strips were pretreated with 0.1 ,M ionomycin for 60 minutes before the application of 128 mM K+ or 10 ,uM acetylcholine. The maximum force induced by 128 mM K' or 10 yM acetylcholine was expressed as relative force. presence of 2 ,uM calmodulin were almost the same as those observed in the absence of calmodulin (Figure 7) . To further investigate the mechanism of action of conh&ol NKH477 on the contractile proteins, the effect of this drug on Ca2 -independent contraction was observed.
The experimental procedure is indicated in Figure 8 .
After maximum contraction was induced by 10 ,uM Ca2 , the strip was rinsed with relaxing solution until it completely relaxed. After the application of rigor solu- The effect of NKH477 on the rigor contraction was also observed. After the application of 10 ,uM Ca2' to the strips, the solution was rinsed off using a Ca2+-free solution with no MgATP; thus, a rigor contraction was produced, as reported previously.33 NKH477 (0.1 ,uM) had no effect on this rigor contraction ( Figure 8B ), suggesting that NKH477 itself did not inhibit actinmyosin interactions directly.
ACh with GTP enhances the Ca2'-induced contraction in a-toxin-treated, chemically skinned smooth muscle strips.3235,36 To investigate the mechanism of action of NKH477 on the Ca2+-induced contraction further, its effect on the contraction induced by Ca21 [Cai+l (nM) removed smooth muscle strips of the porcine coronary artery. ACh (10 ,uM) was applied for 2 minutes after application of Ca2+-free solution containing 2 mM EGTA and 5.9 mM K'. Under these conditions, 10 ,uM ACh transiently increased the amount of 1P3 at 10 seconds. The effect gradually decayed within 60 seconds. 1P3 concentrations were 4.7±1.1 pmol/mg protein (n=3) before the application of 10 ,uM ACh and 9.1+1.6 pmol/mg protein (n=8) 10 seconds after the application of 10 ,uM ACh. The effects of NKH477 on the production of 1P3 induced by 10 ,uM ACh were then measured. NKH477 (0.3 ,uM) had no effect on the synthesis of 1P3 induced by 10 ,uM ACh after 10 seconds (10.2±+1.8 pmol/mg protein in the presence of 0.3 ,iM NKH477, n=5). Forskolin (0.3 ,iM) or isoproterenol (0.1 ,uM) also had no effect on the synthesis of 1P3 activated by 10 ,uM ACh (8.8±+1.4 pmol/mg protein in the presence of 0.1 ,uM isoproterenol, n=4; and 8.7+ 2.7 pmol/mg protein in the presence of 0.3 ,uM forskolin, n=8). Discussion NKH477, a water-soluble forskolin derivative, activates adenylate cyclase. The efficacy of this drug is approximately two times that of forskolin in membrane preparations of the guinea pig ventricle.37 NKH477 up to 0.1 mM did not affect the binding of [3H]CGP12177, a ,B-adrenoceptor ligand in the same preparation.38 In (lower tracing). The muscle strip was treated with 0.1 ttM ionomycin for 60 minutes in Krebs' solution. Ca2+-free solution containing 2 mM EGTA and 5.9 mM K' with 10 tM ACh (indicated as application 1) was then applied for 1 minute; application 1 was followed by the application of Ca2+-free solution containing 2 mM EGTA and 128 mM K' with 10 ,uMACh (application 2). Solutions containing various concentrations of Ca>2 and 128 mM K' with 10 ,uM ACh were cumulatively applied next from low to high concentrations. These solutions contained the the present experiments, NKH477 (>0.1 ,uM) increased cAMP and inhibited the contraction induced by high K' or ACh in muscle strips of porcine coronary artery. These actions of NKH477 were more potent than those of forskolin. Further, NKH477 up to 0.3 ,uM did not increase cGMP even though 0.3 ,uM of the drug produced maximum vasodilation in the presence of high K' or ACh. These results suggest that NKH477 produces vasodilation through a direct activation of adenylate cyclase and that it is more potent than forskolin in smooth muscle of the porcine coronary artery.
In the present experiments, we found that cAMP was increased more by 1 ,uM NKH477 (13.8-fold) than by 0.1 ,uM NKH477, but this drug at 0.1 ,uM maximally inhibited the high K+or ACh-induced contraction. Isoproterenol (0.1 ,uM) increased cAMP to a lesser extent than did 1 ,uM NKH477 but inhibited the high K+or ACh-induced contraction to the same extent as did 1 ,uM NKH477 (the concentrations of cAMP were 156 pmol/mg protein in the presence of 0.1 ,uM isoproterenol and 718.2 pmol/mg protein in the presence of 1 ,uM NKH477). These results suggest that in smooth muscle of the porcine coronary artery, a relatively small (=20-fold) increase in cellular cAMP can cause maximal vasodilation by cAMP-increasing agents. However, the possibility remains that NKH477 may elicit relaxation by mechanisms not involving activation of adenylate cyclase, as reported in the case of forskolin.39'40 was cumulatively applied from low to high concentrations (from 0.3 to 10 ,uM) in the presence or absence of 0.1 ,M NKH477. After the control response was recorded, NKH477 (0.1 itM) was applied in a relaxing solution (indicated by a bar), and Ca2' was cumulatively applied in the presence of NKH477. Finally, the recoveries of the responses were recorded in the absence of NKH477. Panel B: Graph showing pCa-force relations observed in the presence and absence of2 uM calmodulin (CaM) or 0.1 ,uMNKH477. The effects were observed using the same protocol used in panel A. CaM (2 ,M) was applied for 5 minutes before and was present throughout the experiments. The effects of 0.1 ,uM NKH477 in the presence of 2 ,uM CaM (----) were observed using different muscle strips, which were used for the NKH477 effects in the absence of CaM (-). Each symbol represents the mean (n=4), with the SD shown by vertical bars.
In the porcine coronary artery, ACh produces contractions with no change in membrane potential or membrane resistance. 41 In the present experiments, ACh produced a large phasic increase followed by a small tonic increase in [Ca '4] , and generated a sustained contraction. The ACh-induced phasic increase in [Ca4], persisted in Ca'4-free solution42 but disappeared in ionomycin-treated muscle strips in the presence or absence of Ca'4. In contrast, the ACh-induced tonic increase in [Ca2'i persisted in ionomycin-treated muscle strips but was blocked in Ca`4-free solution. These results suggest that the ACh-induced phasic and tonic increases in [Ca '4] i are probably due to the release of Ca 2 from intracellular storage sites and the activation of Ca'4 influx, respectively.
The rate of decline of [Ca '4] i after washout of high K'
or ACh was greatly reduced in ionomycin-treated muscle strips of the porcine coronary artery. lonomycin or A23187, at low concentrations, selectively acts on cellular Ca24 storage sites to release Ca24 and, at high concentrations (> 1 MM), acts on the plasma membrane as a Ca'2 carrier in vascular smooth muscle.43 In the In panel A, the maximum Ca24-induced contraction was recorded by application of 10 puM Ca2`; then Ca2' solution was removed and replaced by relaxing solution (Ca24-free solution containing 4 mM EGTA and 4 mM MgATP) to get full relaxation of the strip. Rigor solution (Ca24-free and ATP-free solution) was then applied for 5 minutes. After application of 2 mM adenosine-5'-0-(3-thiotriphosphate) (ATPyS) with 0.3 ,uM Ca2+ for 20 minutes in rigor solution, the strip was rinsed with rigor solution for 5 minutes, and relaxing solution was applied. When theforce reached a steady level, 0.1 ,M NKH477 was applied. The results were reproducible in two other strips. In panel B, after the maximum Ca2'-induced contraction was evoked by the application of 10 paM Ca21, the strip was rinsed with rigor solution. When the force reached a steady level, 0.1 ,uM NKH477 was applied. The results were reproducible in two other strips. present experiments, 0.1 ,M ionomycin was used and, at this concentration, completely inhibited the AChinduced release of [Ca24]i but slightly increased steadystate [Ca24]1 measured several minutes after application. These results suggest that the slow decline of the [Ca24]1 in ionomycin-treated muscle strips may be due to the loss of function of cellular Ca24 storage sites, indicating that these storage sites may have an important role in determining the rate of decline of [Ca24]i in smooth muscle cells of the porcine coronary artery.
ACh activates the synthesis of IP3 through the hydrolysis of phosphatidylinositol 4,5-diphosphate, and 1P3 releases Ca'2 from the cellular storage sites in smooth muscle of the porcine coronary artery. 44 Thus, 1P3 is a possible second messenger for agonist-induced Ca2' release in various cell types, including vascular smooth muscle.45 It has been found that elevation of cAMP on the pCa-force relation in the presence of 10 p.M acetylcholine (ACh) with 3 ,uM GTP in 83-escin-treated skinned smooth muscle strips ofthe porcine coronary artery. After the muscle strip was skinned by application of f3-escin, Ca2' was cumulatively applied from low to high concentrations (from 0.1 to 10 ,uM) in the absence (control) or presence of 10 ,uM ACh and 3 p.M GTP with or without 0.1 uM NKH477. The experimental protocols were the same as those described in Figure 7A . Each symbol represents the mean (n=4), with the SD shown by vertical bars.
reduces agonist-mediated inositol phosphate formation in platelets,12 neutrophils,13 and A10 (A10, ATCC CRL 1476)-cultured vascular smooth muscle cells.46 cAMPdependent protein kinase reduces the ability of 1P3 to release stored Ca?' through the phosphorylation of the 1P3 receptor in isolated vesicles from brain synaptosomes.'5 cAMP also increases Ca2+ uptake into intracellular storage sites in saponin-skinned smooth muscle of guinea pig and rabbit mesenteric arteries.78,47 In the present experiments, NKH477 slightly inhibited AChinduced release of [Ca2+]. However, NKH477, forskolin, and isoproterenol did not modify ACh-induced 1P3 production in muscle strips of the porcine coronary artery. These results suggest that NKH477 inhibits ACh-induced Ca2+ release but does not inhibit AChinduced IP3 synthesis in smooth muscle of the porcine coronary artery. Further studies are required to clarify the sites of the action of agents that increase cAMP and thereby inhibit agonist-induced Ca'2 release.
NKH477 inhibited the ACh-induced tonic increase in [Ca2"]j, but this. action of NKH477 completely disappeared in ionomycin-treated muscle strips. Since intracellular Ca'+ storage sites were functionally removed in ionomycin-treated muscle strips, these results suggest that NKH477 inhibits the ACh-induced tonic increase In ,B-escin-treated skinned smooth muscle strips of the porcine coronary artery, 0.3 ,M Ca2+ was the threshold for producing a contraction; yet, in the intact strips, when the [Ca2+1] was reduced from the resting level (159 nM) to 98 nM after removal of extracellular Ca2+, the resting force decreased. Since calmodulin (our present results) or a high concentration of GTP (>5 ,uM, authors' unpublished observations) increases the amplitude of Ca2+-induced contraction, these or other cytosolic components may leak out from the skinned cells. Further, we added 10 mM phosphocreatine in the skinned solution to maximize the ATP/ADP ratio in the skinned cells. Since high concentrations of phosphocreatine inhibit the Ca2+-activated force in skinned smooth muscle strips of the rabbit mesenteric artery,33 the solution used for the skinned strips may not be adequate to compare the sensitivity of contractile proteins to Ca2+ between intact and skinned strips. These possibilities warrant further investigation. It is believed that phosphorylation of myosin light chain by Ca2+-calmodulin-dependent myosin light chain kinase is sufficient to regulate smooth muscle contraction, although the coexistence of thin-filament-linked regulation has not been ruled out.2152-54 Sellers and Adelstein55 reported that, after activation of cAMPdependent protein kinase, myosin light chain kinase from gizzard smooth muscle is phosphorylated in vitro. They found that, in the absence of Ca2+-calmodulin, two sites (A and B) of myosin light chain kinase are phosphorylated, whereas in the presence of Ca2'-calmodulin, only one site (B) is phosphorylated. Phosphorylation of the A site decreases the affinity of myosin light chain kinase for Ca2+-calmodulin.21, 55 We previously found that in saponin-treated smooth muscle strips of the rabbit mesenteric artery, cAMP with cAMP-dependent protein kinase shifted the pCa-force relation curve to the right. 47 In the present experiments, NKH477 shifted the pCa-force relation curve to the right and inhibited the maximum contraction induced by 10 gM Ca2' in 13-escin-treated smooth muscle strips of the porcine coronary artery. Since NKH477 did not have any effect on Ca2'-independent contraction in f3-escinand ATPyS-treated smooth muscle, the inhibitory action of NKH477 on Ca2+-induced contraction should relate to the level of phosphorylation of the myosin light chain.
It was recently found that the phosphorylation of myosin light chain kinase in site A is provoked by carbachol or high K', but not by isoproterenol, in bovine tracheal smooth muscle, suggesting that an increase in [Ca2+]i (but not in cAMP) may be responsible for the A-site phosphorylation of myosin light chain kinase. 56 In crude smooth muscle homogenate from swine carotid artery, high K' (but not histamine) stimulation inhibits the [Ca2"]i sensitivity of myosin light chain kinase.57 In the present experiments, NKH477 shifted the pCaforce relation to the right and inhibited the maximum contraction induced by 10 ,M Ca2' in the presence or absence of 2 ,uM calmodulin. Although it is unknown whether the A site of myosin light chain kinase in the skinned muscle is phosphorylated in the presence of NKH477 under our experimental conditions, these results suggest that the phosphorylation of myosin light chain kinase by cAMP-dependent protein kinase may not be the only mechanism for cAMP-induced suppression of Ca2+-induced contraction in ,3-escin-skinned smooth muscle of the porcine coronary artery. Other mechanisms related to the phosphorylation of myosin light chain may also be involved.
In conclusion, NKH477 is a more potent drug than forskolin for increasing the cellular cAMP in smooth muscle of the porcine coronary artery. NKH477 attenuates ACh-induced Ca21 mobilization through its actions on the ionomycin-sensitive Ca2+ storage site. However, this agent did not modify the ACh-induced synthesis of 1P3. NKH477 decreased the sensitivity of the contractile proteins to Ca2' in the presence of high K+ or ACh. Thus, it can be suggested that, in smooth muscle of the porcine coronary artery, NKH477 attenuates ACh-induced contraction by both attenuating ACh-induced Ca2' mobilization and reducing the sensitivity of the contractile machinery to Ca2 , possibly by activating cAMP-dependent mechanisms.
